Brexpa-0.5 Tablet Tablet

About Brexpa-0.5 Tablet 500 mcg

Brexpa-0.5 Tablet is a 500 mcg tablet containing brexpiprazole, made by Renata PLC. It is an atypical antipsychotic used in the treatment of schizophrenia and as an add-on to antidepressants for major depressive disorder.

There are 2 brands of Brexpiprazole listed in Bangladesh.

What is Brexpa-0.5 Tablet 500 mcg?

Brexpa-0.5 Tablet is an atypical antipsychotic medicine in tablet form, with each tablet containing 500 mcg of brexpiprazole. Doctors prescribe it for two main purposes: the treatment of schizophrenia, and as an add-on therapy to antidepressants for major depressive disorder in adults. How brexpiprazole works in these conditions is not fully understood, but it is thought to act on certain serotonin and dopamine receptors in the brain. It belongs to a group sometimes described as benzodiazepine antagonists in its therapeutic classification. Because it is a prescription medicine for mental health conditions, it should only be taken under the supervision of a qualified doctor.

Uses of Brexpa-0.5 Tablet

Brexpa-0.5 Tablet is used for the treatment of schizophrenia and as an additional (adjunctive) treatment alongside antidepressants for major depressive disorder. In both cases it is prescribed by a doctor after an assessment. It is not a general-purpose medicine and should not be started for any other reason. If you are unsure why it has been prescribed for you or a family member, ask the prescribing doctor to explain the reason and what to expect from treatment.

How to use Brexpa-0.5 Tablet

Take Brexpa-0.5 Tablet by mouth, with or without food, as your doctor directs. The doctor decides the dose and how the course is adjusted over time, based on how you respond and how well you tolerate it. Do not change the dose or stop the medicine on your own, because stopping suddenly can cause problems. If you miss a dose, ask your doctor or pharmacist what to do rather than doubling up. Keep to your follow-up appointments so your progress can be checked.

Side effects of Brexpa-0.5 Tablet

Like all medicines, Brexpa-0.5 Tablet can cause side effects, and these vary from person to person. Some people may notice changes such as weight gain, changes in blood sugar or blood fats, or movement-related effects. Because it acts on the brain, some people may experience unusual urges or compulsive behaviours; tell your doctor if this happens. Serious reactions are also possible, including a severe reaction called neuroleptic malignant syndrome and tardive dyskinesia. Ask your doctor or pharmacist for the full list and seek medical help if you feel unwell.

Safety and precautions

Brexpa-0.5 Tablet is a prescription medicine and should be used only under a doctor's supervision. Tell your doctor before starting if you have ever had an allergic reaction to brexpiprazole or any tablet ingredient, since such allergy is a reason not to use it. Because it can affect blood sugar, blood fats, weight and blood counts, your doctor may arrange checks during treatment. Elderly people with dementia-related psychosis need particular care, as do people who develop fever, stiffness or confusion. If you are pregnant, planning pregnancy or breastfeeding, speak to your doctor first; breastfeeding is not advised without medical advice. Always ask your doctor or pharmacist about any concerns.

Frequently asked questions

What is Brexpa-0.5 Tablet used for and what kind of medicine is it?

Brexpa-0.5 Tablet is an atypical antipsychotic containing 500 mcg of brexpiprazole. It is used to treat schizophrenia and, alongside antidepressants, to treat major depressive disorder. It is a prescription medicine, so it should only be taken when a doctor has prescribed it for you.

What does the generic name brexpiprazole mean?

Brexpiprazole is the generic (non-brand) name of the active ingredient in Brexpa-0.5 Tablet. It is the name used for the medicine itself, while Brexpa is the brand name given by the company. Different brands may contain the same generic ingredient, so always check with your pharmacist before switching.

How should Brexpa-0.5 Tablet be stored?

Store the tablets at 20°C to 25°C, with short excursions permitted between 15°C and 30°C. Keep them in their original packaging, away from moisture and out of the reach of children. Do not use tablets after the expiry date, and ask your pharmacist how to dispose of any unused medicine safely.

Can anyone take Brexpa-0.5 Tablet?

No, it is not suitable for everyone. People with a known allergy to brexpiprazole or any ingredient should not take it. Elderly patients with dementia-related psychosis need special caution. Pregnancy, breastfeeding and other health conditions should be discussed with your doctor before starting, and the doctor decides whether it is appropriate for you.

Indications

Brexpiprazole is an atypical antipsychotic indicated for:
  • Use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD)
  • Treatment of schizophrenia

Pharmacology

The mechanism of action of brexpiprazole in the treatment of major depressive disorder or schizophrenia is unknown. However, the efficacy of brexpiprazole may be mediated through a combination of partial agonist activity at serotonin 5-HT1A and dopamine D2 receptors, and antagonist activity at serotonin 5-HT2A receptors.

Dosage & Administration

Adjunctive Treatment of Major Depressive Disorder: The recommended starting dosage for Brexpiprazole as adjunctive treatment is 0.5 mg or 1 mg once daily, taken orally with or without food. Titrate to 1 mg once daily, then up to the target dosage of 2 mg once daily. Dosage increases should occur at weekly intervals based on the patient's clinical response and tolerability. The maximum recommended daily dosage is 3 mg. Periodically reassess to determine the continued need and appropriate dosage for treatment.

Treatment of Schizophrenia: The recommended starting dosage for Brexpiprazole is 1 mg once daily on Days 1 to 4, taken orally with or without food. The recommended target Brexpiprazole dosage is 2 mg to 4 mg once daily. Titrate to 2 mg once daily on Day 5 through Day 7, then to 4 mg on Day 8 based on the patient’s clinical response and tolerability. The maximum recommended daily dosage is 4 mg.

Contraindications

Brexpiprazole is contraindicated in patients with a known hypersensitivity to brexpiprazole or any of its components. Reactions have included rash, facial swelling, urticaria, and anaphylaxis.

Pregnancy & Lactation

There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to Brexpiprazole during pregnancy.

Lactation studies have not been conducted to assess the presence of brexpiprazole in human milk, the effects of brexpiprazole on the breastfed infant, or the effects of brexpiprazole on milk production. Brexpiprazole is present in rat milk. The development and health benefits of breastfeeding should be considered along with the mother’s clinical need for Brexpiprazole and any potential adverse effects on the breastfed infant from Brexpiprazole or from the underlying maternal condition.

Precautions & Warnings

Cerebrovascular Adverse Reactions in Elderly Patients with Dementia-
  • Related Psychosis: Increased incidence of cerebrovascular adverse reactions (e.g. stroke, transient ischemic attack)
  • Neuroleptic Malignant Syndrome: Manage with immediate discontinuation and close monitoring
  • Tardive Dyskinesia: Discontinue if clinically appropriate
  • Metabolic Changes: Monitor for hyperglycemia/diabetes mellitus, dyslipidemia and weight gain
  • Pathological Gambling and Other Compulsive Behaviors: Consider dose reduction or discontinuation
  • Leukopenia, Neutropenia, and Agranulocytosis: Perform complete blood counts (CBC) in patients with pre-existing low white blood cell count (WBC) or history of leukopenia or neutropenia. Consider discontinuing Brexpiprazole if a clinically significant decline in WBC occurs in absence of other causative factors
  • Orthostatic Hypotension and Syncope: Monitor heart rate and blood pressure and warn patients with known cardiovascular or cerebrovascular disease, and risk of dehydration or syncope
  • Seizures: Use cautiously in patients with a history of seizures or with conditions that lower the seizure threshold

Storage Conditions

Store Brexpiprazole tablets at 20°C to 25°C; excursions permitted to 15°C to 30°C

Alternative brands of Brexpiprazole

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.